Rivaroxaban Completed Phase 3 Trials for Superficial Vein Thrombosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01499953Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux